Literature DB >> 12931141

The alpha(2A)-adrenergic agonist guanfacine improves visuomotor associative learning in monkeys.

Min Wang1, Jin-Zhao Ji, Bao-Ming Li.   

Abstract

Two monkeys were trained on two-problem visuomotor associations: if the cue was a circle pattern, move a handle to the left ('go-left'), and if it was a triangle pattern, move the handle to the right ('go-right'). These two visuomotor associations were unchanged throughout all the experiments and therefore were very familiar to the monkeys. For learning of new visuomotor associations, each monkey was presented with a new set of four novel patterns in each and every daily session, two of which instructed 'go-left' response and the other two 'go-right' response. Systemically administered guanfacine, a selective alpha(2A)-adrenergic agonist, improved the monkeys' learning ability: trials and errors to the learning criterion of 90% correct decreased significantly. The monkeys showed an enhanced capability of using at least three response strategies: win-stay on 'repeat trial', change-stay and change-shift on 'change trial'. The beneficial effect could be reversed by the coadministered idaxozan, an alpha(2)-adrenergic antagonist, which had no effect when administered alone. Similar treatment with guanfacine had no beneficial effect on visual discriminative learning, a task that involves the inferotemporal cortex. The present results indicate that stimulation by guanfacine of alpha(2A)-adrenoceptors improves visuomotor associative learning, probably through actions at alpha(2A)-adrenoceptors in the prefrontal cortex.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 12931141     DOI: 10.1038/sj.npp.1300278

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  10 in total

1.  The Emerging Neurobiology of Attention Deficit Hyperactivity Disorder: The Key Role of the Prefrontal Association Cortex.

Authors:  Amy F T Arnsten
Journal:  J Pediatr       Date:  2009-05-01       Impact factor: 4.406

Review 2.  Prefrontal dysfunction and a monkey model of schizophrenia.

Authors:  Ping Mao; Ding Cui; Xu-Dong Zhao; Yuan-Ye Ma
Journal:  Neurosci Bull       Date:  2015-03-31       Impact factor: 5.203

Review 3.  Prefrontal cortical α2A-adrenoceptors and a possible primate model of attention deficit and hyperactivity disorder.

Authors:  Chao-Lin Ma; Xuan Sun; Fei Luo; Bao-Ming Li
Journal:  Neurosci Bull       Date:  2015-03-31       Impact factor: 5.203

Review 4.  The role of guanfacine as a therapeutic agent to address stress-related pathophysiology in cocaine-dependent individuals.

Authors:  Helen Fox; Rajita Sinha
Journal:  Adv Pharmacol       Date:  2014

5.  Lack of effects of guanfacine on executive and memory functions in healthy male volunteers.

Authors:  Ulrich Müller; Luke Clark; Minh L Lam; Rebecca M Moore; C Louise Murphy; Nicola K Richmond; Ranbir S Sandhu; Ingrid A Wilkins; David K Menon; Barbara J Sahakian; Trevor W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

Review 6.  Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction.

Authors:  Amy F T Arnsten
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 7.  Neuronal mechanisms underlying attention deficit hyperactivity disorder: the influence of arousal on prefrontal cortical function.

Authors:  Avis R Brennan; Amy F T Arnsten
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

8.  Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder.

Authors:  Amy Ft Arnsten; Anne G Dudley
Journal:  Behav Brain Funct       Date:  2005-04-22       Impact factor: 3.759

9.  A computational psychiatry approach identifies how alpha-2A noradrenergic agonist Guanfacine affects feature-based reinforcement learning in the macaque.

Authors:  S A Hassani; M Oemisch; M Balcarras; S Westendorff; S Ardid; M A van der Meer; P Tiesinga; T Womelsdorf
Journal:  Sci Rep       Date:  2017-01-16       Impact factor: 4.379

10.  Guanfacine's mechanism of action in treating prefrontal cortical disorders: Successful translation across species.

Authors:  Amy F T Arnsten
Journal:  Neurobiol Learn Mem       Date:  2020-10-17       Impact factor: 2.877

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.